Pharmageddon [[electronic resource] /] / David Healy
(Visualizza in formato marc)
(Visualizza in BIBFRAME)
| Autore: |
Healy David, MRC Psych
|
| Titolo: |
Pharmageddon [[electronic resource] /] / David Healy
|
| Pubblicazione: | Berkeley, : University of California Press, c2012 |
| Descrizione fisica: | 1 online resource (315 p.) |
| Disciplina: | 338.4/76153 |
| Soggetto topico: | Pharmacology |
| Medicine | |
| Soggetto non controllato: | addiction |
| american healthcare | |
| anti-depressants | |
| big pharma | |
| blockbuster drugs | |
| dangers of prescription drugs | |
| drug companies | |
| drug use | |
| evidence based medical system | |
| evidence based medicine | |
| healthcare and drugs | |
| healthcare and pharamceuticals | |
| medical lit | |
| medication side effects | |
| medications and safety | |
| medicine and healthcare | |
| mental illness | |
| pharmaceutical and biotechnology industry | |
| pharmaceutical companies | |
| pharmaceuticalization of medicine | |
| pharmacy books | |
| prescription drug safety | |
| universal healthcare | |
| Note generali: | Description based upon print version of record. |
| Nota di bibliografia: | Includes bibliographical references and index. |
| Nota di contenuto: | They used to call it medicine -- Medicine and the marketeers -- Follow the evidence -- Doctoring the data -- Trussed in guidelines -- The mismeasurement of medicine -- The eclipse of care -- Pharmageddon. |
| Sommario/riassunto: | This searing indictment, David Healy's most comprehensive and forceful argument against the pharmaceuticalization of medicine, tackles problems in health care that are leading to a growing number of deaths and disabilities. Healy, who was the first to draw attention to the now well-publicized suicide-inducing side effects of many anti-depressants, attributes our current state of affairs to three key factors: product rather than process patents on drugs, the classification of certain drugs as prescription-only, and industry-controlled drug trials. These developments have tied the survival of pharmaceutical companies to the development of blockbuster drugs, so that they must overhype benefits and deny real hazards. Healy further explains why these trends have basically ended the possibility of universal health care in the United States and elsewhere around the world. He concludes with suggestions for reform of our currently corrupted evidence-based medical system. |
| Titolo autorizzato: | Pharmageddon |
| ISBN: | 1-283-36974-5 |
| 9786613369741 | |
| 0-520-95181-6 | |
| Formato: | Materiale a stampa  |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione: | Inglese |
| Record Nr.: | 9910821162303321 |
| Lo trovi qui: | Univ. Federico II |
| Opac: | Controlla la disponibilità qui |